MNKD Q2 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$49M+157.3% YoY

Gross Profit

$34M70.7% margin

Operating Income

$2M3.5% margin

Net Income

-$5M-10.8% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+19.7%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$14M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$313M

Total Liabilities

$574M

Stockholders' Equity

-$260M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$19M	+157.3%
Gross Profit	$34M	$6M	+474.9%
Operating Income	$2M	-$20M	+108.4%
Net Income	-$5M	-$29M	+81.9%

Revenue Segments

License and Service

$9M100%